Fluarix Tetra 15 µg / 0.5 ml Sospensione iniettabile

Riik: Šveits

keel: itaalia

Allikas: Swissmedic (Swiss Agency for Therapeutic Products)

Toimeaine:

haemagglutininum influenzae di tipo A (H1N1) (Virus Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derivato da A/Singapore/GP1908/2015), haemagglutininum influenzae A (H3N2) (Virus Stamm A/Hong Kong/4801/2014 (H3N2)-come: reassortant virus NYMC X-263B ), haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lignaggio))

Saadav alates:

GlaxoSmithKline AG

ATC kood:

J07BB02

INN (Rahvusvaheline Nimetus):

haemagglutininum influenzae A (H1N1) (Virus Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singa

Ravimvorm:

Sospensione iniettabile

Koostis:

haemagglutininum influenzae A (H1N1) (Virus Stamm A/Michigan/45/2015 (H1N1)-like: reassortant virus IVR-180 derived from A/Singapore/GP1908/2015) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Hong Kong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B ) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Brisbane/60/2008 (Victoria lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, residui: ovalbuminum max. 0.05 µg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nihil, hydrocortisonum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

Terapeutiline rühm:

Vaccini

Terapeutiline ala:

Immunizzazione attiva contro l'Influenza, a partire da 36 Mesi

Loa andmise kuupäev:

2014-05-28